Ibutamoren
Ibutamoren
Ibutamoren (pronounced: i-bu-ta-mo-ren), also known as MK-677, is a non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue. It is an investigational new drug developed for the treatment of conditions such as growth hormone deficiency and osteoporosis.
Etymology
The term "Ibutamoren" is derived from the combination of chemical elements present in the drug. The prefix "Ibu-" is derived from the chemical element Iodine (I), the middle "-tam-" is derived from the chemical element Tantalum (Ta), and the suffix "-oren" is derived from the chemical element Oxygen (O) and Rhenium (Re).
Usage
Ibutamoren is used to stimulate the production of growth hormone and insulin-like growth factor 1 (IGF-1) without affecting the levels of other hormones such as cortisol. It is also used in the treatment of muscle wasting associated with conditions such as HIV and cancer.
Side Effects
Potential side effects of Ibutamoren include increased appetite, mild lower extremity edema, and muscle pain. Long-term use may lead to increased risk of diabetes and changes in lipid metabolism.
Related Terms
- Ghrelin receptor
- Growth hormone
- Insulin-like growth factor 1
- Cortisol
- Muscle wasting
- HIV
- Cancer
- Diabetes
- Lipid metabolism
External links
- Medical encyclopedia article on Ibutamoren
- Wikipedia's article - Ibutamoren
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski